Claritin-D 12-Hour Allergy Relief Tablets from Canada
Combination tablets with loratadine and pseudoephedrine sulfate for allergy symptom relief including nasal congestion. Falls under HTS 3004.42.00.00 due to pseudoephedrine salt content in measured doses put up for retail sale as a mixed therapeutic product. Specifically identifies pseudoephedrine as the classifying alkaloid per subheading.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit FDA import alerts documentation and ensure pseudoephedrine does not exceed DEA threshold limits per shipment
• Labeling must specify exact pseudoephedrine content; common pitfall is incomplete NDC numbers leading to holds
• Verify stability data for combination products to meet Chapter 30 retail sale requirements